A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses-Reference-Cited by-同舟云学术

A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses

Published:2011-08-12 Issue:6044 Volume:333 Page:843-850
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Ekiert Damian C.¹,Friesen Robert H. E.²,Bhabha Gira¹,Kwaks Ted²,Jongeneelen Mandy²,Yu Wenli¹,Ophorst Carla²,Cox Freek²,Korse Hans J.W.M.²,Brandenburg Boerries²,Vogels Ronald²,Brakenhoff Just P.J.²,Kompier Ronald²,Koldijk Martin H.²,Cornelissen Lisette A.H.M.³,Poon Leo L. M.⁴,Peiris Malik⁴,Koudstaal Wouter²,Wilson Ian A.¹⁵,Goudsmit Jaap²

Affiliation:

1. Department of Molecular Biology, Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.

2. Crucell Holland BV, Archimedesweg 4-6, 2301 CA Leiden, Netherlands.

3. Central Veterinary Institute, Wageningen University, Houtribweg 39, 8221 RA Lelystad, Netherlands.

4. State Key Laboratory of Emerging Infectious Diseases and Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong, China.

5. Skaggs Institute for Chemical Biology, Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.

Abstract

An antibody against a conserved epitope broadly neutralizes group 2 influenza viruses.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference37 articles.

1. Current and future antiviral therapy of severe seasonal and avian influenza

2. Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States

3. Resistant influenza A viruses in children treated with oseltamivir: descriptive study

4. Influenza Virus Transmission: Basic Science and Implications for the Use of Antiviral Drugs During a Pandemic

5. The contents of the syringe

Cited by 768 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing;International Journal of Biological Macromolecules;2024-10

2. Emerging trends and therapeutic applications of monoclonal antibodies;Gene;2024-10

3. Rapid discovery of monoclonal antibodies by microfluidics-enabled FACS of single pathogen-specific antibody-secreting cells;Nature Biotechnology;2024-08-14

4. Exploiting the Affimer platform against influenza A virus;mBio;2024-08-14

5. An explainable language model for antibody specificity prediction using curated influenza hemagglutinin antibodies;Immunity;2024-08